How much is Mariana Oncology worth in 2026?

Mariana Oncology has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Mariana Oncology raised?

Mariana Oncology has raised N/A in total funding across 2 funding rounds.

Mariana Oncology

Drug Discovery

Mariana Oncology valuation and funding history | Last updated: August 25, 2023 | 2 funding rounds

Current Valuation

N/A

As of August 25, 2023

Total Funding Raised

N/A

Across 2 rounds

Last Round

Early Stage VC (Series B)

$173.9M

Last Funding

Aug 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 25, 2023	Early Stage VC (Series B)	$173.9M	N/A	-
December 1, 2021	Early Stage VC (Series A)	$75.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Mariana Oncology is currently valued at N/A as of August 25, 2023.

Track Mariana Oncology Valuation Updates

Get notified when Mariana Oncology raises new funding or valuation changes

Explore More Data

Detailed analysis for Mariana Oncology

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Mariana Oncology's valuation history, funding rounds, and growth metrics.

No credit card required

What is Mariana Oncology Worth in 2026?

Mariana Oncology is a leading private company in the Drug Discovery sector. Track Mariana Oncology's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Mariana Oncology Valuation is Determined

Private company valuations like Mariana Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.